China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of China Pharma (NYSE:CPHIFree Report) in a research report report published on Saturday morning. The firm issued a hold rating on the stock.

China Pharma Price Performance

China Pharma stock opened at $0.32 on Friday. China Pharma has a 1 year low of $0.30 and a 1 year high of $2.70. The business has a 50-day moving average of $0.38 and a 200-day moving average of $0.48. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.33 and a current ratio of 0.88.

About China Pharma

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Further Reading

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.